Advertisement

Hematology/Oncology

  • Arpan A. Sinha
  • Scott Moerdler
  • Ellen Fraint
  • Adit Tal
  • Nora E. Rahmani
  • Kerry MorroneEmail author
Chapter

Abstract

This chapter is a brief but comprehensive overview of topics that will be tested in the Pediatric Boards. It covers a wide range of conditions, including benign hematology, malignant hematology, bone tumors, brain tumors, and abdominal masses. It discusses the differential diagnoses, pathophysiology, workup, classic laboratory features, and treatment options for a range of pediatric hematologic and oncologic conditions. This is a high yield review for the pediatric boards.

Keywords

Anemia Hemoglobinopathy Thrombocytopenia Tumors Leukemia Lymphoma Bone marrow failure 

Notes

Acknowledgment

The authors gratefully acknowledge the contributions of Staci Bryson, MD, and Arlynn F. Mulne, MD, Department of Pediatrics, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA, to the 1st edition of this chapter, from which some images and tables have been incorporated into this edition as well.

References

  1. 1.
    Kliegman R, Stanton B, St. Geme JW III, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. Philadelphia: Elsevier; 2016.Google Scholar
  2. 2.
    Loghavi S, Hasserjian RP. Cytopenias: reactive and neoplastic. In: Wang SA, Hasserjian RP, editors. Diagnosis of blood and bone marrow disorders. Cham: Springer International. p. 17–80.Google Scholar
  3. 3.
    Rogers HJ. Normal bone marrow. In: George TI, Arber DA, editors. Atlas of bone marrow pathology. New York: Science+Business Media; 2018.Google Scholar
  4. 4.
    Schafernak KT, Calvo KR. Constitutional, metabolic, and related disorders. In: George TI, Arber DA, editors. Atlas of bone marrow pathology. New York: Science+Business Media; 2018. p. 33–66.CrossRefGoogle Scholar
  5. 5.
    Penanchansky L. Pediatric bone marrow. Berlin: Springer; 2004.CrossRefGoogle Scholar

Suggested Reading

  1. Adams M, Jenney M, Lazarou L, White R, Birdsall S, Staab T, et al. Acute myeloid leukaemia after treatment for acute lymphoblastic leukaemia in girl with Bloomsyndrome. J Genet Syndr Gene Ther. 2013;4(8). pii: 1000177.Google Scholar
  2. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.CrossRefGoogle Scholar
  3. Adams RJ, Brambilla D, Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353(26):2769–78.CrossRefGoogle Scholar
  4. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.CrossRefGoogle Scholar
  5. Bain B. Diagnosis from the blood smear. N Engl J Med. 2005;353(5):498–507.CrossRefGoogle Scholar
  6. Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ, General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update. Br J Haematol. 2012;156(1):37–49.CrossRefGoogle Scholar
  7. Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA, van den Heuvel-Eibrink MM, et al. Acute lymphoblastic leukemia in children with Down Syndrome: a retrospective analysis from the Ponte Di Legno study group. Blood. 2014;123(1):70–7.CrossRefGoogle Scholar
  8. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–43.CrossRefGoogle Scholar
  9. DeLoughery T. Microcytic anemia. New Engl J Med. 2014;371(14):1324–31.CrossRefGoogle Scholar
  10. Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, Euro Histio Network, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60(2):175–84.CrossRefGoogle Scholar
  11. Horton TM, Steuber CP, Aster JC. Park JR, editor. Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children. Waltham: UpToDate. http://www.uptodate.com. Accessed 24 Dec 2018.
  12. Karimi M. Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014–10;31:583–96.Google Scholar
  13. Kliegman R, Stanton B, St. Geme JW III, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. Philadelphia: Elsevier; 2016.Google Scholar
  14. Levin TL, Mäkitie O, Berdon WE, Lachman RS. Shwachman–Bodian–Diamond Syndrome: metaphyseal chondrodysplasia in children with pancreatic insufficiency and neutropenia. Pediatr Radiol. 2015;45(7):1066–71. Review.CrossRefGoogle Scholar
  15. Lipton JM. Evaluation of pancytopenia. BMJ Best Practice (database). 2018. https://bestpractice.bmj.com/topics/en-us/1024. Accessed 24 Dec 2018.
  16. McClain KL. Kaplan SL, Mahoney Jr DH, Drutz JE, editors. Peripheral lymphadenopathy in children: evaluation and diagnostic approach. Waltham: UpToDate. http://www.uptodate.com. Accessed 24 Dec 2018.
  17. Medeiros LJ, Greiner TC. Hodgkin’s disease. Cancer. 1995;75(1 Suppl):357–69.CrossRefGoogle Scholar
  18. Nathan DG, Oski FA, Orkin SH, editors. Nathan and Oski’s hematology and oncology of infancy and childhood, vol. 2. Philadelphia: Elsevier Saunders; 2015.Google Scholar
  19. Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. Oncologist. 2009;14(2):164–73.CrossRefGoogle Scholar
  20. Rai KR, Stilgenbauer S, Aster JC. Larson RA, editor. Clinical features and diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. Waltham: UpToDate Inc. http://www.uptodate.com. Accessed 24 Dec 2018.
  21. Schrier SL. Mahoney Jr DH, editor. Acquired aplastic anemia in children and adolescents. Waltham: UpToDate. http://www.uptodate.com (Accessed 24 Dec 2018
  22. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017;92(1):94–108.CrossRefGoogle Scholar
  23. Van Etten RA. Larson RA, editor. Clinical manifestations and diagnosis of chronic myeloid leukemia. Waltham: UpToDate. http://www.uptodate.com. Accessed 24 Dec 2018
  24. Vannucchi AM. How I treat polycythemia vera. Blood. 2014;124(22):3212–20.CrossRefGoogle Scholar
  25. Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, BABY HUG Investigators, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778):1663–72.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Arpan A. Sinha
    • 1
  • Scott Moerdler
    • 2
  • Ellen Fraint
    • 3
  • Adit Tal
    • 3
  • Nora E. Rahmani
    • 3
  • Kerry Morrone
    • 3
    Email author
  1. 1.Jimmy Everest Center of Pediatric Hematology and Oncology, Department of PediatricsThe University of Oklahoma Health Sciences CenterOklahoma CityUSA
  2. 2.Pediatric Hematology/Oncology Program, Department of PediatricsRutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers UniversityNew BrunswickUSA
  3. 3.Division of Pediatric Hematology, Oncology, Marrow and Blood Cell Transplantation, Department of PediatricsChildren’s Hospital at MontefioreBronxUSA

Personalised recommendations